Dilemma of belimumab therapy (dis)continuation during pregnancy: Results of a retrospective study in eudravigilance

INTRODUCTION: The first biologic authorized for systemic lupus erythematosus (SLE) up to this date, belimumab, is currently not recommended for use during pregnancy due to lack of data. Provided that the health of the child begins with the health of the mother, pregnant patients face the dilemma of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghalandari, Nafise, Crijns, Hubertina JMJ, Dolhain, Radboud JEM, Hazes, Johanna MW, van Puijenbroek, Eugene P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939929/
https://www.ncbi.nlm.nih.gov/pubmed/36448410
http://dx.doi.org/10.1177/09612033221143286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939929/
https://www.ncbi.nlm.nih.gov/pubmed/36448410
http://dx.doi.org/10.1177/09612033221143286

Ejemplares similares